J&J's Rybrevant Receives FDA Nod for Expanded Use in NSCLC
Johnson & Johnson JNJ announced that the FDA approved a combination therapy involving EFGR/MET inhibitor Rybrevant ...
GE Vernova to trim offshore wind unit, slashing hundreds of jobs
GE Vernova ( GEV) cited cost inflation and supply chain challenges that have hurt the wind sector over the last year, but it ...
Can the Fed’s rate cut change biotech’s ‘new normal’?
Industry insiders hope the Fed’s decision to cut rates for the first time in years will boost biotech investment. But the ...
The Bakersfield Californian3d
Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247
Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle ...
labiotech4d
Estonia: Seven biotech companies to reckon with
Explore Estonia’s biotech scene with 7 pioneering companies across Tallinn, Tartu, and beyond, fueled by top science parks ...